NCCN Guidelines® Insights: Multiple myeloma, version 3.2022: Featured updates to the NCCN Guidelines Guidelines
| Authors: | Callander, N. S.; Baljevic, M.; Adekola, K.; Anderson, L. D. Jr; Campagnaro, E.; Castillo, J. J.; Costello, C.; Devarakonda, S.; Elsedawy, N.; Faiman, M.; Garfall, A.; Godby, K.; Hillengass, J.; Holmberg, L.; Htut, M.; Huff, C. A.; Hultcrantz, M.; Kang, Y.; Larson, S.; Liedtke, M.; Martin, T.; Omel, J.; Sborov, D.; Shain, K.; Stockerl-Goldstein, K.; Weber, D.; Berardi, R. A.; Kumar, R.; Kumar, S. K. |
| Title: | NCCN Guidelines® Insights: Multiple myeloma, version 3.2022: Featured updates to the NCCN Guidelines |
| Abstract: | The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with various plasma cell neoplasms, including multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates/changes specific to the treatment of patients with multiple myeloma in the 2022 version of the guidelines. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 20 |
| Issue: | 1 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2022-01-01 |
| Start Page: | 8 |
| End Page: | 19 |
| Language: | English |
| DOI: | 10.6004/jnccn.2022.0002 |
| PUBMED: | 34991075 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 February 2022 -- Source: Scopus |
